Physician profile
Andrew Weitzel
NPI 1811916950
$4,252.97
in general payments reported to CMS, 2019-2025
35 companies · $49.37 in 2025
The $49.37 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $590 · 2020: $635 · 2021: $386 · 2022: $1,072 · 2023: $791 · 2024: $730 · 2025: $49.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,570.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $440.26 | 2019-2024 | Aveed, Xiaflex, Edex |
| Janssen Biotech, INC. | $361.87 | 2019-2024 | Erleada |
| Astellas Pharma US INC | $335.13 | 2019-2023 | Myrbetriq |
| Axonics, INC. | $330.76 | 2020-2023 | Axonics, Bulkamid |
| Medtronic USA, INC. | $292.93 | 2019-2020 | |
| Teleflex LLC | $279.82 | 2024 | Urolift |
| Edap Technomed INC | $258.31 | 2022 | |
| Boston Scientific Corporation | $171.02 | 2019-2023 | Spaceoar Vue System - 10ml |
| Abbvie INC. | $163.74 | 2019-2025 | Botox |
| Myriad Genetic Laboratories, INC. | $144.17 | 2021-2024 | Prolaris |
| Bayer Healthcare Pharmaceuticals INC. | $136.49 | 2020-2024 | |
| Coloplast Corp | $135.25 | 2020-2024 | Speedicath |
| Procept Biorobotics Corporation | $129.69 | 2024 | Aquabeam System |
| Antares Pharma, INC. | $129.07 | 2019-2023 | Xyosted, Tlando, Nocdurna |
| Allergan, INC. | $127.36 | 2019-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $122.89 | 2021-2022 | |
| Tolmar, INC. | $102.71 | 2023-2024 | |
| Myovant Sciences INC. | $71.00 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $66.00 | 2019-2022 | |
| Endo USA, INC. | $57.28 | 2024 | Xiaflex, Edex, Aveed |
| Valencia Technologies Corporation | $52.40 | 2023 | Ecoin Device Kit |
| Telix Pharmaceuticals | $47.72 | 2024 | Illuccix |
| Pfizer INC. | $40.51 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $34.94 | 2023-2025 | Gemtesa |
| Halozyme INC | $31.58 | 2023 | |
| Merck Sharp & Dohme LLC | $26.97 | 2023 | Lynparza |
| Olympus America INC. | $25.03 | 2023 | Itind System |
| Blue Earth Diagnostics | $19.30 | 2019 | |
| Urovant Sciences INC | $18.70 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.62 | 2022 | |
| Convatec INC. | $17.53 | 2022 | |
| Accord Healthcare, INC. | $17.46 | 2022 | |
| Ferring Pharmaceuticals INC. | $17.33 | 2019 | |
| Laborie Medical Technologies Corp. | $17.16 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $11.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Weitzel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.